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Abstract: Diabetic retinopathy (DR) is the leading cause of visual loss in working-age adults 
worldwide. Previous studies have found hemodynamic changes in the diabetic eyes, which 
precede clinically evident pathological alterations of the retinal microvasculature. There is a 
pressing need for new methods to allow greater understanding of these early hemodynamic 
changes that occur in DR. In this study, we propose a noninvasive method for the assessment 
of hemodynamics around the fovea (a region of the eye of paramount importance for vision). 
The proposed methodology combines adaptive optics scanning laser ophthalmoscopy and 
computational fluid dynamics modeling. We compare results obtained with this technique 
with in vivo measurements of blood flow based on blood cell aggregation tracking. Our 
results suggest that parafoveal hemodynamics, such as capillary velocity, wall shear stress, 
and capillary perfusion pressure can be noninvasively and reliably characterized with this 
method in both healthy and diabetic retinopathy patients. 
© 2016 Optical Society of America 
OCIS codes: (170.4460) Ophthalmic optics and devices; (330.4300) Vision system - noninvasive assessment; 
(110.1080) Active or adaptive optics; (330.4060) Vision modeling. 
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1. Introduction 
As the worldwide prevalence of diabetes mellitus continues to increase, diabetic retinopathy 
(DR) remains the most common vascular complication in diabetic patients [1]. The chronic 
hyperglycemic state of diabetes results in pathological alterations of retinal microvascular 
structures and blood flow abnormalities. Currently, despite advances in the treatment, DR 
remains the leading cause of visual loss in working-aged people worldwide [2,3]. New 
approaches are necessary in order to best understand how to prevent vision loss from diabetic 
eye complications, particularly in the early stages of this disease. 
The fovea centralis, nourished in part by a network of small caliber retinal capillaries, is 
the area of the retina responsible for sharp central vision and visual detail. This foveal 
capillary network supplies nutrients and oxygen and disposes of cellular byproducts to 
maintain neural retinal function [4]. Central retinal function depends greatly on the foveal 
microcirculation. However, this network is compromised in many diabetic patients by chronic 
hyperglycemia, which leads to structural alterations in the capillaries and changes in blood 
flow, even in early stages of diabetes [5]. If left untreated, these changes can lead to 
substantial, sometimes irreversible vision loss in diabetic patients. 
Given the importance of the parafoveal capillary network, the ability to visualize and 
assess subtle alterations in this portion of the retinal vasculature, even before visual loss has 
occurred, is critical for a full understanding of the association between early structural 
pathology and later functional impairments. Current standard retinal imaging techniques, such 
as optical coherence tomography (OCT), color fundus photography or fluorescein 
angiography (FA) are widely used to provide information on healthy and diseased vascular 
structures [6]. However, these technologies fail to visualize the finest capillary network due to 
limited imaging resolution, or involve the invasive use of contrast agents, which may be 
associated with the risk of adverse reactions [7,8]. More importantly, the aforementioned 
techniques do not generally provide information about parafoveal capillary hemodynamics, 
which may be essential for best prediction of future development of vascular pathology over 
the chronic course of diabetes. 
Several authors have worked on the characterization of the blood flow changes associated 
with DR disease progression. An early example is the work by Mendívil et al. who 
prospectively compared blood flow velocity in the various ocular vessels (ophthalmic artery, 
posterior ciliary arteries, central retinal vessels, and vortex veins) between proliferative DR 
(PDR) patients and age-matched controls [9]. Their results show a statistically significant 
reduction in blood velocity in the DR patients. In a series of subsequent studies, Burgansky-
Eliash et al. confirmed these findings in the retinal arterioles and venules of nonproliferative 
DR (NPDR) patients but found the opposite trend in the patients with early diabetes mellitus 
that do not show clinical signs of DR [5,10]. These findings speak in favor of a model where 
hemodynamic changes precede structural alterations of the retinal vasculature in DR. All the 
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above-mentioned studies focus on measuring blood flow on retinal arterioles, venules or 
capillaries of relatively large caliber due to the resolution limitations associated with imaging 
the parafoveal region. More recently, Arichika et al. used adaptive optics scanning laser 
ophthalmoscopy (AOSLO) to measure the velocity of erythrocyte aggregation flowing in the 
parafoveal region and found a statistically significant increase in NPDR patients compared to 
PDR and control groups [11]. An additional limitation of these studies is that they focus 
exclusively on the analysis of blood velocity but not other important hemodynamic variables 
such as wall shear stress (WSS). There exists mounting evidence (see [12,13] and references 
therein) that WSS is a key player in both developmental and pathological vascular processes. 
Indeed, it has been suggested that pathologically enhanced WSS could be behind the 
suppression of endothelial pro-survival factors seen in DR [14]. 
In this study, we used AOSLO with computational fluid dynamics (CFD) in order to 
construct computational blood flow models capable of recapitulating the hemodynamic 
environment (blood velocity, WSS, and perfusion pressure) of the smallest capillaries in the 
parafoveal region of the retina. We hypothesize that our flow models will provide similar 
results to in vivo blood velocity measurements obtained by tracking blood cell aggregation 
(BCA, mostly individual slow-moving leukocytes followed by a cluster of erythrocytes) 
visible in the AOSLO scans [11] and present BCA tracking data for the capillary networks 
assessed in this study for flow model validation purposes. Finally, we show that the proposed 
methodology is applicable, with similar degree of accuracy, to both diabetic and nondiabetic 
subjects. We conclude that our approach enables detailed hemodynamic characterization of 
the parafoveal region beyond what is directly observable experimentally and that it can 
provide valuable information in order to establish the relationship between early 
hemodynamic changes and DR disease progression. 
2. Methods 
2.1 Study participants recruitment 
In the study, eyes were classified into two groups: diabetic and nondiabetic (control). The 
control group included four eyes from three healthy, nondiabetic study participants with no 
history of ocular or systemic diseases. The diabetic group included four eyes from three 
additional participants, all with type 1 diabetes of duration from 19 to 29 years. Two eyes had 
mild NPDR, one eye had severe NPDR and one eye had quiescent PDR. Pupil dilation was 
performed on all diabetic participants 20 minutes before imaging. No pupil dilation was 
performed on healthy control participants, but during imaging, the room light was turned off 
to ensure maximum pupil size. In the non-dilated control group, the pupil size was ≥5 mm in 
order to maintain image quality. Participant’s demographics are shown in Table 1. Except for 
the participant with severe NPDR, who had hypertension, all other participants had blood 
pressure within normal limits on the day of the study visit. Both the severe NPDR and PDR 
participants were on lipid lowering medications. The study was approved by the Joslin 
Diabetes Center Institutional Review Board and was consistent with the Declaration of 
Helsinki. 
Table 1. Study Eye and Participant Demographics 
Eye Age (yrs.) Sex Group HbA1c* (%) 
Diabetes 
Duration (yrs.) DR Status 
IOP* 
(mmHg) 
Visual 
Acuity 
1 37 F Diabetes 8.6 19 Mild NPDR 15 20/20 
2 37 F Diabetes 8.6 19 Mild NPDR 15 20/20 
3 35 F Diabetes 8.1 29 Quiescent PDR 14 20/16 
4 25 F Diabetes 8.0 20 Severe NPDR 18 20/16 
5 32 M Control Not measured N/A N/A 12 20/20 
6 32 M Control Not measured N/A N/A 11 20/20 
7 31 M Control Not measured N/A N/A 17 20/20 
8 31 F Control Not measured N/A N/A 11.5 20/20 
*HbA1c = Hemoglobin A1c (normal range 4% - 5.6%, 5.7% - 6.4% indicates increased risk of diabetes, 6.5% or 
higher indicates diabetes), measured within 3 months of the study visit. IOP = Intraocular pressure. 
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2.2 Imaging system setup 
The AOSLO used in this study was a modified version of the Indiana system described 
previously [15]. The schematic layout of the system is shown in Fig. 1. The AOSLO uses two 
superluminescent diodes (SLD) for imaging and wavefront sensing, with central wavelengths 
of 830 nm and 780 nm respectively (BLM-S-830 and BLM-S-780, Superlum, Ireland). A 
micro-electro-mechanical system deformable mirror (DM, Multi-DM, Boston Micromachines 
Corp., Cambridge, MA, USA) was used to provide wavefront correction. The DM has an 
active area of 4.95 mm × 4.95 mm and 12 × 12 actuators with a maximum stroke of 5.5 µm. 
The system uses doubler mirrors to amplify the usable stroke of the DM [16] (the beam path 
for the doubler is not shown in Fig. 1 for the sake of simplicity). The maximum beam size at 
the exit pupil is 6.5 mm. Based on theoretical calculations, this AOSLO system is capable of 
compensating for >90% of the optical aberrations from an eye with clear media and a dilated 
pupil, achieving ~2.5 µm resolution. 
 
Fig. 1. AOSLO system schematic layout (not to scale). 
Return light from the retina passes through a confocal aperture that is optically conjugated 
to the retinal plane. The apertures vary in size and are mounted on a 3-axis motorized stage 
(MT3-Z8, Thorlabs, NJ, USA). The stage allows precise positioning of the apertures for 
different imaging modes. In the study, we used two imaging modes: 3 × Airy disk aperture for 
confocal imaging when the aperture was placed in the center position, and 10 × Airy disk 
aperture for multiply scattered light imaging (also known as pinhole offset imaging [17]). The 
pinhole is displaced at negative 5 Airy disk diameters in both the X and Y directions away 
from the center regardless of vessel orientation. The axial resolution for the multiply scattered 
light imaging mode is approximately 150 µm with the large confocal pinhole. 
2.3 Light safety 
The AOSLO output power at the cornea is 183µW for the imaging SLD, and 67µW for the 
wavefront sensing SLD. The SLD on/off state is modulated with the resonance mirror. The 
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SLD is on during the fore-scan of the resonance mirror, and is at the off state on the back-
scan to reduce light exposure time. Superluminescent light levels on the retina are at least five 
times below the safety thresholds set by the American National Standards Institute ANSI 
Z136.1 [18]. 
2.4 Image processing and luminal surface reconstruction 
50-frame videos (29 frames/sec, 1.75° × 1.75° area) were captured, aligned and averaged with 
a custom-made MATLAB (The MathWorks, Inc., Natick, MA, USA) program. Motion 
contrast perfusion maps were then generated to highlight the parafoveal capillary network. 
This motion contrast technique is similar to what was used by Tam et al. [19], but with the 
AOSLO focus set at the plane of the retinal vasculature using multiply scattered light imaging 
[17] rather than at the plane of the photoreceptors for direct visualization of BCA movement 
and more precise rendering of the vessel lumen boundaries. Ten frames with the largest 
intensity variations were selected from the 50 frame video to calculate the perfusion map on a 
pixel-by-pixel basis. These perfusion maps were then manually montaged to form 5° × 5° 
greyscale images, with approximately 20% overlap to ensure accurate image alignment. Fine 
alignment errors from image montaging were minimized by utilizing the “Auto-Blend Layers 
(Panorama)” function in Photoshop (CS6, Adobe Systems, Inc., San Jose, CA, USA). 
Frangi filtering [20] (as implemented in the ImageJ software package) was applied to the 
images to enhance tubular structures followed by global image thresholding. Manual editing 
was performed by a trained grader to correct errors in the vascular structure such as 
discontinuities in the vessel network after image thresholding. The resulting binary masks 
were used to reconstruct a three-dimensional (3D) model of the luminal surface of the vessels 
based on the methodology previously described in [21]. Briefly, binary masks were processed 
with MATLAB in order to compute the graph associated with the image skeleton, calculate 
vessel radii (lumen width from perfusion maps divided by 2) along the network, and register 
radii to the graph. 
The computed graph underwent two automatic post-processing operations to remove 
artifacts introduced during imaging and manual editing: caliber normalization and vessel 
crossing correction. Caliber normalization involved enforcing a minimum vessel diameter of 
6 µm. This operation was performed in order to remove artificial narrowing, which would 
otherwise result in inaccurate portrayal of vessel segments of high resistance, artificially 
reducing flow upstream/downstream from them. This, in turn, would affect the values of WSS 
computed by the flow model. Second, vessel crossing correction involved applying a 
transformation to the network graph to account for the fact that the AOSLO scans were two-
dimensional (2D) projections of a 3D vascular network and therefore graph nodes with four 
incident edges corresponded to vessels running past each other at different depths. These 
nodes can be easily identified in the network graph and the four incident edges can be paired 
up based on the intersecting angles they define. Each of these pairs of edges was then 
translated in opposite directions (assigned randomly) along the axis perpendicular to the 2D 
projection. Enough distance between the two resulting segments was ensured, based on the 
radii computed, to avoid contact. Finally, a 3D triangulation of the luminal surface was 
generated based on the corrected network graph and radii with the software package VMTK 
(Orobix srl). 
2.5 Blood flow simulation 
Briefly, blood flow was modeled according to the Navier-Stokes equations for generalized 
Newtonian incompressible fluids. Let Ω  be a three-dimensional domain with boundary Ω∂ . 
For Ω Ω∈ ∪ ∂x  and time Ω Ω∈ ∪ ∂x  
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where ( )ˆ , Ωn ∂x x , is the boundary normal vector, ( )oP t  is the reference pressure at the 
outlet, and iv  is the velocity at the inlet as a function of the distance to vessel centerline, r , 
under the vessel circular cross-section assumption. 
In order to construct computational blood flow models of the capillary networks under 
study, we require for each imaged eye: a) a definition of the flow domain Ω  (e.g. the 
previously described reconstruction of the network luminal surface), b) a characterization of 
blood flow at the boundaries of the domain (i.e. inlets, outlets, and vessel walls), i.e. , i oPv  
and c) an appropriate blood rheological model, η . 
The inlets and outlet of the network are the closed surfaces defined by the open ends of 
the vessels that connect the subset of the retinal vasculature imaged to the rest of the 
cardiovascular system. The arteriolar/venular identity of the inlets/outlets was determined by 
registration to a 100° wide field fundus photograph (see Fig. 2). 
Blood flow was assumed to be steady and a constant flow rate was imposed at the inlets of 
the model. A reference pressure 0oP =  mmHg was set at the outlets and therefore the 
computed pressure field P should be interpreted as a pressure difference with regards to the 
network outlets. Given the technical difficulty of measuring iv  in vivo on the participants of 
our study, we approximated it based on existing literature [10]. In the study by Burgansky-
Eliash et al., the authors measured blood velocities in the arterioles and venules that feed and 
drain the parafoveal region of the retina. Measurements were classified in three groups 
according to vessel caliber (<10 µm, 10-20 µm, >20 µm), which were consistent with our 
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own measures of vessel caliber. The study characterized NPDR and control eyes separately 
and found that arteriolar velocity (and therefore flow rate) depends on vessel caliber in both 
groups. Building on these results, our procedure for approximating iv  is as follows. Given the 
radius Ri of any given inlet i, we define the inlet centerline velocity Vmax as the mean velocity 
given in Table 4 of [10] for the relevant eye type and vessel caliber subgroups. We use the 
NPDR measurements in [10] for all our DR flow models, irrespectively of disease stage. The 
velocity profile at the inlet i is given by 
 ( )
2
21  ,ˆi max
i
rr V
R
 
= −  
v n   
i.e. a parabolic velocity profile, assuming vessel circular cross-section. Blood velocity is 
taken to be zero at the vessel walls (i.e. no-slip boundary condition). Flow simulations were 
run with the computational fluid dynamics software package HemeLB ([21], 
https://github.com/UCL/hemelb). Details regarding the validation of the numerical solver are 
provided in [21] and [22]. Convergence of the steady-state flow simulations was checked 
according to the criterion described in Eq. (4).4) of [21] with a relative tolerance of 1e-5. 
At a constitutive level, blood is a dense suspension of cells in an aqueous medium known 
as blood plasma. This configuration leads to complex rheological properties such as the shear 
thinning and Fåhræus-Lindqvist effects [23]. It is often argued that in larger vessels, these 
effects are secondary. However, when modeling blood flow in capillaries, they must be taken 
into account in order to correctly capture the changes in blood viscosity occurring along the 
capillary beds under study. In the current work, we use the Carreau-Yasuda shear-thinning 
rheology model parameterized with human data as presented in [24]. See Section 4 for a 
discussion on the limitations of this approach. 
HemeLB was used to compute high-resolution estimates of pressure, velocity, and WSS 
across the parafoveal capillary networks under study. On average, over 600,000 data points 
were generated across each vascular network. Simulations were run using 48 cores of 
ARCHER, UK’s national supercomputing service (http://www.archer.ac.uk). Each simulation 
took around 10 minutes to complete. Flow visualizations were generated with Paraview 
(Kitware, Inc.) and post-processing of the results was performed with custom-made Python 
scripts. 
2.6 Flow simulation validation strategy 
Several authors have reported the presence of BCA visible as bright, mobile particles 
followed by a dark trail in AOSLO scans when the focal plane was set at the cone layers 
[11,25]. In our study, we took advantage of this AOSLO feature, but with a shift of focus to 
the vessel layer for the validation of the reconstructed blood flow models. In particular, we 
hypothesized that our flow models would be able to predict the flow velocity of the BCA 
found in specific locations of the parafoveal capillary network. 
We used the multiple scattered light imaging mode to directly capture the motion of BCA 
at the vessel layer, as shown in Fig. 2. The measurement of the BCA velocity is performed in 
three steps. First, we identify the location of a BCA in a vessel segment with sequential 
frames at a fixed frame rate (29 frames/sec). Second, we follow the BCA movement 
trajectory along the capillary and measure the trajectory path length using ImageJ in those 
sequential frames. The trajectory path length is adjusted based on an individualized 
conversion factor calculated from each participant’s axial length measured by IOLMaster 
(Carl Zeiss Meditec, Inc., Dublin CA, USA). Third, the velocity is determined by using the 
trajectory path length measured in the previous step divided by the time elapsed over the 
succession of the frames. 2-6 BCA locations were identifiable in each parafoveal network, 
with 32 vessel segments in total. In order to reduce error, the velocity of the BCA was 
calculated based on an average of 3 repeated measurements. 
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We use the following procedure to compare the measured BCA velocity with the flow 
model results. First, using a custom-made MATLAB graphical tool, we obtain the coordinates 
of an arbitrary number of equidistant points along the centerlines of each of the paths defined 
by the travelling BCA. Then, using a custom-made Python script, we obtain the velocity 
value predicted by the flow model at each of those points, average them, and compare this 
average value with the BCA velocity values estimated from the AOSLO scans. 
3. Results 
3.1 Image acquisition and processing 
Figure 2 presents the AOSLO perfusion map of an eye in the control group overlaid against a 
standard fundus image. The AOSLO standard deviation perfusion map technique provides 
much higher resolution than the associated fundus photograph and successfully resolves the 
parafoveal vasculature to a level of detail suitable for the segmentation of individual vessels. 
In contrast, the larger field of the associated fundus image allows the determination of the 
arteriolar/venular nature of the parafoveal network inlets/outlets by tracing these vessels back 
towards their origin at the optic nerve. 
 
Fig. 2. AOSLO perfusion maps montaged at fovea over fundus photograph. Control group case 
(Eye #5). Scale bar = 500 µm. 
The left panel of Fig. 3 shows the central 5° × 5° of the perfusion map in Fig. 2. A number 
of arterioles and venules radially approach the fovea to feed/drain the innermost capillaries. In 
the parafoveal region, capillaries are organized concentrically with the innermost ring being 
approximately 250 µm from the center of the foveal avascular zone. The innermost capillaries 
are organized in a single layer and then start to form overlapping anterior and posterior 
plexuses as they move further away from the fovea. 
The right panel of Fig. 3 presents the results of our segmentation workflow applied to the 
previous image. We found that application of the Frangi filter allowed enhancement of 
tubular structures in the image such that, following filter application, most background noise 
could be removed by thresholding. This approach does, however, still require manual 
correction by a trained retinal image grader in order to correct discontinuities and artificial 
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narrowing of vessels, especially in regions where the signal-to-noise ratio is low. This manual 
intervention is time consuming and may present a challenge for reproducibility. 
 
Fig. 3. Parafoveal capillary network from control group (Eye #5). Left: central 3 ° × 3° of the 
capillary network (Auto-Blended in Photoshop). Right: segmentation results from AOSLO 
image with the same field of view. Scale bar = 100µm. 
3.2 Flow model construction and simulation 
Figure 4 shows the 3D luminal surface reconstruction generated from the binary mask in Fig. 
3. The close-up view on the right panel shows one of the vessel crossings corrected using the 
algorithm described in Section 2.4. 
 
Fig. 4. 3D view of the reconstructed luminal surface with close-up of one of the corrected 
vessel crossings (indicated by the arrow). 
Capillary perfusion pressure (CPP) and WSS maps of one control (Eye #5) and one DR 
(Eye #4, Severe NPDR) case are shown in Fig. 5. In the left panel, CPP is defined, at any 
given point, as the pressure difference with respect to the network outlets. The right panel in 
the same figure plots the WSS magnitude on the luminal surface of the vessels. We observe 
how feeding arterioles experience the highest magnitudes of WSS in the domain, which is 
consistent with the experimental observations of [26]. In addition, we observe that WSS 
gradients correlate with vessel narrowing and branching points. 
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 Fig. 5. CPP and WSS map from a control (Eye #5, top panel) and DR case (Eye #4, bottom 
panel). Left panel: CPP across the network (defined as the pressure difference with respect to 
the network outlets). Right panel: WSS magnitudes across the network. Scale bar = 100µm. 
Figure 6 highlights the subsets of the network in Eye #5 perfused by two different inlets 
(labelled with solid arrow heads). In the left panel, it can be observed how the superior, 
temporal quadrant is almost exclusively perfused by inlet A, with some contribution from B 
but none from C. In the right panel, we observe a similar pattern in the superior, nasal 
quadrant, which is almost exclusively perfused by inlet C, with some contribution from D but 
none from A. In this particular subject, we observe a clear spatial affinity between the 
innermost parts of the network and the neighboring feeding arterioles. 
 
Fig. 6. Subsets of the network from Eye #5 directly perfused by two of the dominant inlets 
(solid arrowheads) in the superior half of the parafoveal region (left and right panel, 
respectively). Colored streamlines define the path followed by the bloodstream starting at each 
of the inlets labeled with solid arrowheads. Additional neighboring inlets are labeled with 
empty arrowheads. Streamlines were computed based on the simulation results with the 
Paraview (Kitware Inc.) software. 
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3.3 Velocity, WSS and CPP results 
Table 2 presents the computed mean ± SD values of velocity, WSS, and CPP from each data 
set. Mean velocity ranges from 0.51 to 0.85 mm/s, mean WSS ranges from 1.67 to 2.71 Pa, 
and mean CPP ranges from 3.67 to 6.92 mmHg. 
Table 2. Summary statistics of the main hemodynamic variables of interest for all the 
flow models developed. Velocity, wall shear stress magnitude (WSS), and capillary 
perfusion pressure (CPP). 
Eye Velocity (mm/s) WSS (Pa) CPP (mmHg) 
1 0.58 ± 0.88 1.72 ± 2.12 4.14 ± 2.85 
2 0.82 ± 1.51 2.71 ± 4.35 6.00 ± 8.29 
3 0.76 ± 1.12 2.69 ± 3.11 6.92 ± 8.27 
4 0.85 ± 1.18 2.69 ± 2.98 7.00 ± 5.76 
5 0.51 ± 0.84 1.67 ± 2.50 3.67 ± 4.49 
6 0.75 ± 1.13 2.49 ± 2.99 6.45 ± 5.96 
7 0.80 ± 1.17 2.33 ± 2.34 6.48 ± 4.51 
8 0.85 ± 1.09 2.32 ± 2.29 5.33 ± 3.78 
3.4 Blood velocity validation 
In order to validate our flow models, the computed blood velocity, Velm, by the model and the 
BCA velocity, Vela, were compared. Mean Velm was 0.80mm/s, whereas the mean Vela was 
0.71mm/s, both of which are well within the expected range for blood velocity in capillaries 
of this size caliber [25,27]. The mean difference between Velm and Vela was 0.11mm/s. For 
individual eyes, values for Velm approximated those obtained for Vela (see Fig. 7 for 
example). Of the 32 vessel segments where velocity was estimated, 44% differed by < 0.5 
fold, 69% by < 0.75 fold and 97% by < 1 fold. No statistically significant differences were 
seen in Velm and Vela variability between DR vs. control eyes or between eyes with varying 
DR severity. Detailed velocity results calculated from the two methods are shown in Table 3. 
 
Fig. 7. Top left panel: BCA tracking vessel segments in Eye #5. Top right panel: Velocity 
results comparison between BCA tracking and flow model in Eye #5. Bottom left panel: BCA 
tracking vessel segments in Eye #4. Bottom right panel: Velocity results comparison between 
BCA tracking and flow model in Eye #4. Highlighted segments are where path with visible 
BCA. 
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 Fig. 8. Example of BCA tracking in 5 sequential frames in Eye #5, Segment #3 (Fig. 7 top left 
panel). Frame rate 29 Hz (Visualization 1). 
Table 3. Comparison on velocity between BCA tracking vs. flow model 
Eye No. of segments 
Vela (mm/s)  Velm (mm/s) 
Minimum Maximum Mean ± SD  Minimum Maximum Mean ± SD 
1 5 0.53 0.89 0.64 ± 0.15  0.14 0.54 0.38 ± 0.18 
2 2 0.61 0.76 0.69 ± 0.11  0.42 0.48 0.45 ± 0.05 
3 4 0.60 1.28 0.99 ± 0.32  0.10 0.50 0.34 ± 0.32 
4 3 0.91 1.42 1.14 ± 0.26  0.80 2.48 1.70 ± 0.84 
5 6 0.34 1.09 0.78 ± 0.29  0.04 1.17 0.55 ± 0.42 
6 4 0.66 1.09 0.82 ± 0.19  0.09 0.72 0.34 ± 0.31 
7 4 0.38 0.74 0.62 ± 0.16  0.39 1.18 0.84 ± 0.40 
8 4 0.72 0.79 0.76 ± 0.04  0.06 3.14 1.12 ± 1.43 
Measurement variability when determining vessel segment length is inevitable. We tried 
to minimize this type of error by using the mean value of three independent measurements at 
each vessel segment. On average, the standard deviation of the three measurements was 5 
pixels, which was equivalent to a Vela uncertainty of ± 0.14 mm/s (Vela standard deviation 
error bar shown in Fig. 7 for each segment. Some error bars are invisible due to minimal 
variation between measurements. Velm error bars are not shown because the values are from 
deterministic computer simulations, which don’t account for the sources of variability). When 
quantifying moving object using AOSLO with raster scanners, velocity errors due to the flow 
direction and eye motions are also expected [28]. Due to the randomness of the vessel 
orientation and the curvature, as well as the stabilization in the image post-processing, the up-
mentioned error were not included in this study. Our mean values of the Velm and Vela were 
consistent with mean BCA velocity values (0.32 to 1.16 mm/s) that were reported by 
researchers who used blue-field entoptic phenomenon [27], by researchers who used AOSLO 
for BCA velocity measurement (0.77 to 2.10 mm/s) [25], and by researchers who recently 
used AOSLO multiply scattered light mode with dual-channel scanning technique on 
erythrocytes velocity measurement (0.82 to 1.88 mm/s) [29]. 
4. Discussion 
In this study, we have demonstrated that the AOSLO motion contrast processing technique 
[19] allows non-invasive assessment of the human parafoveal capillary network with 
sufficient resolution for computational blood flow modeling. This approach enables, for the 
first time, detailed hemodynamic characterization of these vessels, which are of paramount 
importance for sharp central vision and are often compromised in diabetic patients. The 
velocities estimated in study eyes by the computational modeling approach fall well within 
the range of previous blood flow estimates for capillaries of this caliber and are similar to 
velocity measurements obtained by direct visualization of BCA within the same vessel 
segments, suggesting that this is a valid method for noninvasive determination of blood flow 
in the parafoveal capillary network. 
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No significant difference between blood velocity was found between diabetic and 
nondiabetic eyes in this small cohort, but this preliminary, feasibility study was not 
specifically powered to detect differences between these groups. Although the small sample 
sizes of this study do not allow the drawing of definitive conclusions about differences in 
blood velocity, WSS or CPP between diabetic versus nondiabetic eyes, we anticipate that the 
proposed methodology could provide valuable information in order to establish the 
relationship between early hemodynamic changes and DR disease progression in future 
studies recruiting larger sample sizes. 
We performed validation of our flow models based on AOSLO BCA tracking. Our results 
demonstrate a modest correlation between model predictions and BCA tracking results. Our 
mean BCA velocity was 0.71 mm/s. The reconstructed flow models predicted a mean velocity 
of 0.80 mm/s in the same segments where the BCA were found. This predicted value lies 
within the range previously reported in the literature [25,27,29]. We also note that the 
measured BCA velocity is only a surrogate for the typical blood velocity at a given point in 
the network. This is due to the fact that, in the BCA, leukocytes have a typical size similar to 
or in excess of the diameter of the vessels that they flow in, therefore they are slowed down 
due to friction with the endothelium. Indeed, it has been argued [11] that this is the reason 
why erythrocytes cluster upstream from them and become visible in the AOSLO scans. 
Furthermore, dark tails in [11] tend to disappear when the BCA reach larger vessels, possibly 
due to the ability of erythrocytes to overtake slower moving particles or the removal of the 
spatial constraints that slow down BCA in capillaries. In a recent reference [29], the authors 
have demonstrated erythrocyte tracking using a dual-beam raster-scan imaging system in the 
retinal capillary. This is a promising technique that might directly assess or further confirm 
capillary hemodynamics as estimated by computational modeling. 
The main limitations of the study are related to image processing, luminal surface 
reconstruction, and blood flow simulation. With respect to image processing, the process of 
perfusion map stitching proved technically challenging, since vessel continuity had to be 
preserved to a high degree of accuracy. Furthermore, there was a substantial degree of 
variability in the luminosity levels of each individual map. This difficult semi-automated 
vessel recognition and segmentation required a highly skilled operator to correct vessel 
discontinuities. We applied an assumption of a 6 µm minimal vessel diameter to help correct 
for artificial narrowing and discontinuity seen most frequently in the smallest vessels. This 
approach may potentially reduce differences due to pathologic narrowing less than 6 µm in 
some eyes and can be refined further in later investigations. Finally, in order to be able to 
simulate flow with the current approach, only completely closed networks could be isolated 
from the AOSLO scans. This introduces a degree of uncertainty since some segments have to 
be excluded if they appeared blind at one of their ends. It will be critical to address this issue 
in future studies to best understand how selecting a portion of the vessel network impacts the 
estimation of WSS and CPP values, particularly at the boundaries of the selected area. With 
regards to luminal surface reconstruction, our current approach considers the lumen to be a 
smooth surface and does not account for microstructures like the glycocalyx, which have been 
shown to play an important role in microvascular hemodynamics [30] and are often 
compromised on type-1 diabetic patients [31]. 
The authors believe that recent advances in imaging technology could help ameliorate 
these issues. Rosen et al. have successfully combined AOSLO and FA in order to further 
increase the imaging resolution and signal to noise ratio [32–34], which could help to address 
some of the image processing challenges previously discussed. In such systems, a blue 
channel (~488nm) light source was added for the fluorescein excitation, while maintaining the 
capability correcting the ophthalmic aberrations from the cornea and lens to reach theoretical 
limited imaging performance. However, it should be noted that the inclusion of a blue light 
source makes the imaging procedure more difficult for patients to comfortably tolerate. More 
importantly, the time and the light level or exposure must be strictly controlled according to 
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the ANSI standard for the safe use of laser, and should be below both the photochemical and 
the thermal maximum permissible exposure limits, limiting the time that can be spent imaging 
with blue light. Besides light safety concerns, adverse reactions to the fluorescein contrast 
agent are well documented. Although these are rarely severe, they further limit the use of FA 
for some patients. 
Another promising approach to speed up the extraction of vessel network is optical 
coherence tomography (OCT) angiography. OCT angiography was first introduced by Huang 
et al. in 2014 [35], and it quickly gains attention from the ophthalmology community. It uses 
erythrocyte movement against the static feature as intrinsic contrast to provide perfusion 
information of the retinal vessel network without fluorescent dye injections. It is particularly 
useful in evaluation of age-related macular degeneration (AMD) and DR by revealing both 
neovascularization as well as areas of vascular non-perfusion [36,37]. Several current 
available OCT angiography systems (e.g. AngioVue by Optovue, and AngioPlex by Zeiss) 
provide volumetric macular scans consist of 3 × 3 mm with a 1.6 mm depth in less than 3 
seconds, comparing to ~10 minutes for FA. OCT angiography also gives good depth 
resolution to acquire en face images of the superficial capillary plexus, deep capillary plexus 
and outer retina choriocapillaris with reasonably good separation of the layers. In theory, 
OCT angiography is an excellent candidate for use in retinal vessel network hemodynamics 
modeling due to its quickness and large field of view. However, our preliminary work using 
OCT angiography images (results not shown here) indicates that it is challenging to generate 
full parafoveal network models that include the smallest, most central retinal capillaries, due 
to the limited spatial resolution (10µm/pixel with OCT angiography comparing to 1µm/pixel 
on the AOSLO). Nevertheless, we believe that OCT angiography will be well suited for this 
modeling technique, if the resolution is enhanced in the future (as with multi-MHz A-scan 
rates OCT that has been reported [38]). 
With regards to our approach to blood flow simulation, the main limitations are the use of 
non-patient specific boundary conditions and a homogeneous shear-thinning rheology model. 
For the former, it is currently not possible to extract from the AOSLO scans the all required 
information to define flow rates at individual inlets and outlets of the model. Thus, we 
decided to compute those flow rates based on published results of typical blood velocities in 
retinal vessels of similar caliber obtained with the Retinal Function Imager imaging modality 
[10]. In future work, we will explore the feasibility of using the BCA velocity measurements 
to infer the flow rates at the inlets and outlets. For the latter, although the shear-thinning 
properties of blood were taken into account, our rheology model fails to capture some of the 
non-Newtonian properties of blood that arise from the particle suspension nature of blood 
(e.g. the Fåhræus–Lindqvist effect). Several authors have shown that it is possible to simulate 
blood as a suspension of deformable particle flowing in plasma and have studied the errors 
introduced by the homoegenous approximation [39–41]. In future work, we will evaluate 
whether this approach is computationally tractable when applied to complex parafoveal 
networks such as the ones reconstructed in the current study. 
5. Conclusion 
Despite their potential utility for DR assessment, no experimental measurements of the main 
parafoveal hemodynamic variables, other than capillary velocity, are available. In this study, 
we have successfully characterized the parafoveal hemodynamics in diabetic and healthy 
human eyes by incorporating high-resolution AOSLO imaging and CFD modeling. Capillary 
velocity, WSS and CPP, were computed in eyes ranging across multiple severity levels of 
DR. Modeling results from computed blood velocity were compared to in vivo velocity 
measurements based on BCA tracking. To our best knowledge, this is the first time that these 
three variables have been reported in the human parafoveal region. In summary, the 
combination of non-invasive imaging technology and advanced computer modeling allows 
evaluation of the central retina in vivo, providing quantitative insight into the hypothesized 
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relationship between hemodynamics and disease progression. In the future, the computational 
modeling approach described here may be compatible with other imaging technologies such 
as AOSLO-FA and OCT angiography which may further extend the capabilities of this 
technique. 
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